COVID-19 rapid diagnostic test AMPLIQUICK®

SARS-COV-2nasopharyngealmolecular

BIOSYNEX AMPLIQUICK® SARS-CoV-2 is an in vitro molecular diagnostic test for the qualitative detection of SARS-CoV-2 (the virus responsible for Covid-19) using RNA extract obtained from nasopharyngeal or salivary samples. This test detects two molecular targets of SARS-CoV-2 located on the RdRp and E genes. Sample Collection: BIOSYNEX AMPLIQUICK® Sample Collection / Kit of 100 swabs + 100 tubes of transport medium RNA Extraction: BIOSYNEX AMPLIQUICK® Lysis – Rapid lysis kit in 15 minutes – 96 well microplates pre-filled with lysis buffer – Compatible with most commercial RNA extraction kits Pathogen and target genes: SARS-Cov-2 / RdRp and E Internal control: RNaseP Reaction media: 96-well microplates pre-filled with the Master Mix – + and – control tubes provided Number of tests: 480 Detection limits: – Extracted and purified RNA : SARS-CoV-2: 1 copy / µL – BIOSYNEX AMPLIQUICK® Lysis: SARS-CoV-2: 1 copy / µL Compatible thermal cyclers: For 0.1 or 0.2 mL low-profile block with FAM, HEX and Cy5 detection channels (refer to the instructions) Sample Collection Nasopharyngeal or salivary specimen collection kit containing transport medium and swab Lysis Rapid lysis kit – microplates pre-filled with ready-to-use lysis medium